| Domestic sales | Marketing and distribution of specialty pharmaceutical formulations in the domestic Indian market. | Established distributor relationships and specialized product portfolio with advanced therapeutic focus. | B2B clients including hospitals, pharmacies, and healthcare providers. | Niche specialty drugs with limited competition in chronic and rare disease treatment segments. | 17 | 31 | Sales revenue from finished pharmaceutical products to hospitals and distributors within India. | Direct sales based on product contracts and volume agreements. | Increasing domestic demand for specialty medicines and chronic disease management therapies. | |
| Export sales | Export and distribution of specialty pharmaceutical products to over 35 countries worldwide. | Wide international footprint and strong collaboration with overseas distributors linked to health ministries. | B2B customers including foreign government health ministries and private hospitals. | High-value specialty biologics and rare disease treatments exported internationally. | 40 | 69 | Sales revenue from international contracts with overseas distributors and health ministries. | Contractual sales with overseas partners, often supported by long-term agreements. | Growing global demand for advanced specialty medicines and strategic collaborations abroad. | |
